NASDAQ

Indaptus Therapeutics, Inc. (INDP)

♥ 684 Thanks from members

Live price chart, market sentiment, and community perspectives for Indaptus Therapeutics, Inc. (NASDAQ: INDP).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Indaptus LeadershipLeadership: Jeffrey Mehler (CEO)Holder: Dedicated Life Science FundsHolder: Institutional InvestorsDecoyPlatform ImmunotherapyAdvanced Oncology Treatments#INDP#Indaptus Therapeutics#NASDAQ#Biotech Stock#Immunotherapy